WARMINSTER, Pa., April 21, 2022 Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target. | April 21, 2022
Preliminary Data Shows that Arbutus Capsid Inhibitor, AB-836 is Generally Safe and Well-Tolerated and Provides Robust Antiviral Activity WARMINSTER, Pa., Dec. 01, 2021 . | December 1, 2021
Arbutus Appoints Lisa M. Caperelli as Vice President, Investor Relations forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.